Results 1 to 10 of about 73,703 (332)

A QALY is [still] a QALY is [still] a QALY? [PDF]

open access: goldBMC Medical Ethics
Despite clinical evidence of drug superiority, therapeutic modalities, like combination immunotherapy, are mostly considered cost-ineffective due to their high costs per life year(s) gained.
Hamideh Mahdiani   +2 more
doaj   +3 more sources

Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries [PDF]

open access: yesCost Effectiveness and Resource Allocation
Introduction Lipid-lowering therapy is central to cardiovascular disease (CVD) management. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors (alirocumab, evolocumab) and inclisiran offer greater low-density lipoprotein cholesterol (LDL-C ...
Samad Azari   +8 more
doaj   +2 more sources

Epidemiological and pharmacoeconomic aspects of HIV infection in military

open access: yesЖурнал инфектологии, 2021
The goals of the research are to determine the latent morbidity and financial losses of the Russian Ministry of Defense due to the dismissal of service members with HIV infection at symptomatic stages; to establish the supposed clinical and ...
Yu. I. Bulankov   +6 more
doaj   +1 more source

The relative value of different QALY types [PDF]

open access: yes, 2020
The oft-applied assumption in the use of Quality Adjusted Life Years (QALYs) in economic evaluation, that all QALYs are valued equally, has been questioned from the outset.
Bulfone, Liliana   +6 more
core   +2 more sources

Modelling the Health Economic Impact of Influenza Vaccination Strategies for High-Risk Children in Vietnam [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Introduction: In Vietnam, since 2011 a National Influenza Surveillance System in Vietnam has implemented Severe Acute Respiratory Infection (SARI) surveillance to assemble information and inform administrational and methods of prevention.
Trung Quang Vo   +3 more
doaj   +1 more source

The Great I-QALY Disaster

open access: yesINNOVATIONS in Pharmacy, 2020
The QALY is an impossible construct; it defies common sense. It fails completely once we consider the axioms of fundamental measurement. Utilities as ordinal scales cannot be used to create QALYS. The QALY should never have been introduced to support the
Paul Langley
doaj   +1 more source

How to allocate scarce health resources without discriminating against people with disabilities [PDF]

open access: yes, 2016
One widely used method for allocating health care resources involves the use of cost-effectiveness analysis (CEA) to rank treatments in terms of quality-adjusted life-years (QALYs) gained.
John, Tyler M.   +2 more
core   +1 more source

THE USE OF PALBOCKLIB, A CYCLINE-DEPENDENT KINASE 4/6 INHIBITOR, IN THE TREATMENT OF METASTATIC BREAST CANCER. A COST-CONSEQUENCE ANALYSIS

open access: yesСибирский онкологический журнал, 2017
A new generation of aromatase inhibitors and target therapy directed at cycline-dependent kinases 4 and 6 gives a new opportunity to treat metastatic breast cancer. However, the cost of innovative therapy remains high.
S. L. Pavlinsky, P. I. Shabalkin
doaj   +1 more source

Opportunities for improving the efficiency of paediatric HIV treatment programmes [PDF]

open access: yes, 2015
Objectives: To conduct two economic analyses addressing whether to: routinely monitor HIV-infected children on antiretroviral therapy (ART) clinically or with laboratory tests; continue or stop cotrimoxazole prophylaxis when children become stabilized on
Bakeera-Kitaka, S   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy